A Study of Canagliflozin + Metformin Hydrochloride Immediate Release (IR) Fixed-Dose Combination as an Adjunct to Diet and Exercise to Improve Glycemic Control in Indian Adult Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus Intervention: Drug: Canagliflozin + Metformin hydrochloride (Fixed Dose Combination) Sponsor: Johnson & Johnson Private Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Endocrinology | Fortamet | India Health | Invokana | Metformin | Nutrition | Research | Sports Medicine | Study